Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Myolite is a private ophthalmology-focused medical device company developing protective lighting technologies intended to reduce the incidence of myopia and slow myopia progression. Publicly visible information centers on patented and patent-pending lighting systems that simulate aspects of outdoor light exposure and direct controlled electromagnetic radiation to the eye. The company appears to be focused on non-drug, device-based refractive therapy rather than traditional pharmaceutical development. Available evidence suggests it remains an active private company in Florida, but there is limited public disclosure regarding commercial products, clinical trials, financing, or a broad operating pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Myolite.